APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Grade CBD Oil

Compare research editions
View pricing & licenses

Selected research

Industry Research

Pharmaceutical Grade CBD Oil Industry Research Report 2026

31 December 2025134 pages

Choose your research edition.

Industry ResearchPharmaceutical Grade CBD Oil Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Grade CBD Oil Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Grade CBD Oil Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Grade CBD Oil Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Grade CBD Oil Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Pharmaceutical Grade CBD Oil market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Pharmaceutical Grade CBD Oil is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Pharmaceutical Grade CBD Oil is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Grade CBD Oil is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Pharmaceutical Grade CBD Oil include Absolute Terps, Aphria, Cannavest, Canopy Growth Corporation, CBD American Shaman, Charlotte's Web, Emblem Cannabis Oils, ENDOCA and Folium Biosciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Pharmaceutical Grade CBD Oil market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Pharmaceutical Grade CBD Oil Market by Company

Absolute Terps

Aphria

Cannavest

Canopy Growth Corporation

CBD American Shaman

Charlotte's Web

Emblem Cannabis Oils

ENDOCA

Folium Biosciences

GL Brands, Inc.

Green Road

HempLife Today

K.I.N.D. Concentrates

Kazmira

Medical Marijuana, Inc.

NuLeaf Naturals

PHARM-CBD, LLC

The Lab

Whistler

Pharmaceutical Grade CBD Oil Segment by Type

Full Spectrum CBD Oil

Broad Spectrum CBD Oil

Pharmaceutical Grade CBD Oil Segment by Application

Anxiety

Diabetes

Fibromyalgia

Others

Pharmaceutical Grade CBD Oil Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Grade CBD Oil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Grade CBD Oil and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Grade CBD Oil.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Pharmaceutical Grade CBD Oil manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Pharmaceutical Grade CBD Oil by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Pharmaceutical Grade CBD Oil in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pharmaceutical Grade CBD Oil Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Pharmaceutical Grade CBD Oil Sales (Tons) of Manufacturers (2021-2026) Table 7. Global Pharmaceutical Grade CBD Oil Sales Market Share by Manufacturers (2021-2026) Table 8. Global Pharmaceutical Grade CBD Oil Revenue of Manufacturers (2021-2026) Table 9. Global Pharmaceutical Grade CBD Oil Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Pharmaceutical Grade CBD Oil Average Price (US$/Kg) of Manufacturers (2021-2026) Table 11. Global Pharmaceutical Grade CBD Oil Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Pharmaceutical Grade CBD Oil, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Pharmaceutical Grade CBD Oil, Product Type & Application Table 14. Global Pharmaceutical Grade CBD Oil Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Pharmaceutical Grade CBD Oil by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Absolute Terps Company Information Table 19. Absolute Terps Business Overview Table 20. Absolute Terps Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 21. Absolute Terps Pharmaceutical Grade CBD Oil Product Portfolio Table 22. Absolute Terps Recent Developments Table 23. Aphria Company Information Table 24. Aphria Business Overview Table 25. Aphria Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 26. Aphria Pharmaceutical Grade CBD Oil Product Portfolio Table 27. Aphria Recent Developments Table 28. Cannavest Company Information Table 29. Cannavest Business Overview Table 30. Cannavest Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 31. Cannavest Pharmaceutical Grade CBD Oil Product Portfolio Table 32. Cannavest Recent Developments Table 33. Canopy Growth Corporation Company Information Table 34. Canopy Growth Corporation Business Overview Table 35. Canopy Growth Corporation Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 36. Canopy Growth Corporation Pharmaceutical Grade CBD Oil Product Portfolio Table 37. Canopy Growth Corporation Recent Developments Table 38. CBD American Shaman Company Information Table 39. CBD American Shaman Business Overview Table 40. CBD American Shaman Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 41. CBD American Shaman Pharmaceutical Grade CBD Oil Product Portfolio Table 42. CBD American Shaman Recent Developments Table 43. Charlotte's Web Company Information Table 44. Charlotte's Web Business Overview Table 45. Charlotte's Web Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 46. Charlotte's Web Pharmaceutical Grade CBD Oil Product Portfolio Table 47. Charlotte's Web Recent Developments Table 48. Emblem Cannabis Oils Company Information Table 49. Emblem Cannabis Oils Business Overview Table 50. Emblem Cannabis Oils Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 51. Emblem Cannabis Oils Pharmaceutical Grade CBD Oil Product Portfolio Table 52. Emblem Cannabis Oils Recent Developments Table 53. ENDOCA Company Information Table 54. ENDOCA Business Overview Table 55. ENDOCA Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 56. ENDOCA Pharmaceutical Grade CBD Oil Product Portfolio Table 57. ENDOCA Recent Developments Table 58. Folium Biosciences Company Information Table 59. Folium Biosciences Business Overview Table 60. Folium Biosciences Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 61. Folium Biosciences Pharmaceutical Grade CBD Oil Product Portfolio Table 62. Folium Biosciences Recent Developments Table 63. GL Brands, Inc. Company Information Table 64. GL Brands, Inc. Business Overview Table 65. GL Brands, Inc. Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 66. GL Brands, Inc. Pharmaceutical Grade CBD Oil Product Portfolio Table 67. GL Brands, Inc. Recent Developments Table 68. Green Road Company Information Table 69. Green Road Business Overview Table 70. Green Road Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 71. Green Road Pharmaceutical Grade CBD Oil Product Portfolio Table 72. Green Road Recent Developments Table 73. HempLife Today Company Information Table 74. HempLife Today Business Overview Table 75. HempLife Today Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 76. HempLife Today Pharmaceutical Grade CBD Oil Product Portfolio Table 77. HempLife Today Recent Developments Table 78. K.I.N.D. Concentrates Company Information Table 79. K.I.N.D. Concentrates Business Overview Table 80. K.I.N.D. Concentrates Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 81. K.I.N.D. Concentrates Pharmaceutical Grade CBD Oil Product Portfolio Table 82. K.I.N.D. Concentrates Recent Developments Table 83. Kazmira Company Information Table 84. Kazmira Business Overview Table 85. Kazmira Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 86. Kazmira Pharmaceutical Grade CBD Oil Product Portfolio Table 87. Kazmira Recent Developments Table 88. Medical Marijuana, Inc. Company Information Table 89. Medical Marijuana, Inc. Business Overview Table 90. Medical Marijuana, Inc. Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 91. Medical Marijuana, Inc. Pharmaceutical Grade CBD Oil Product Portfolio Table 92. Medical Marijuana, Inc. Recent Developments Table 93. NuLeaf Naturals Company Information Table 94. NuLeaf Naturals Business Overview Table 95. NuLeaf Naturals Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 96. NuLeaf Naturals Pharmaceutical Grade CBD Oil Product Portfolio Table 97. NuLeaf Naturals Recent Developments Table 98. PHARM-CBD, LLC Company Information Table 99. PHARM-CBD, LLC Business Overview Table 100. PHARM-CBD, LLC Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 101. PHARM-CBD, LLC Pharmaceutical Grade CBD Oil Product Portfolio Table 102. PHARM-CBD, LLC Recent Developments Table 103. The Lab Company Information Table 104. The Lab Business Overview Table 105. The Lab Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 106. The Lab Pharmaceutical Grade CBD Oil Product Portfolio Table 107. The Lab Recent Developments Table 108. Whistler Company Information Table 109. Whistler Business Overview Table 110. Whistler Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 111. Whistler Pharmaceutical Grade CBD Oil Product Portfolio Table 112. Whistler Recent Developments Table 113. Global Pharmaceutical Grade CBD Oil Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 114. Global Pharmaceutical Grade CBD Oil Sales by Region (2021-2026) & (Tons) Table 115. Global Pharmaceutical Grade CBD Oil Sales Market Share by Region (2021-2026) Table 116. Global Pharmaceutical Grade CBD Oil Sales by Region (2027-2032) & (Tons) Table 117. Global Pharmaceutical Grade CBD Oil Sales Market Share by Region (2027-2032) Table 118. Global Pharmaceutical Grade CBD Oil Revenue by Region (2021-2026) & (US$ Million) Table 119. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Region (2021-2026) Table 120. Global Pharmaceutical Grade CBD Oil Revenue by Region (2027-2032) & (US$ Million) Table 121. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Region (2027-2032) Table 122. North America Pharmaceutical Grade CBD Oil Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. North America Pharmaceutical Grade CBD Oil Sales by Country (2021-2026) & (Tons) Table 124. North America Pharmaceutical Grade CBD Oil Sales by Country (2027-2032) & (Tons) Table 125. North America Pharmaceutical Grade CBD Oil Revenue by Country (2021-2026) & (US$ Million) Table 126. North America Pharmaceutical Grade CBD Oil Revenue by Country (2027-2032) & (US$ Million) Table 127. Europe Pharmaceutical Grade CBD Oil Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Europe Pharmaceutical Grade CBD Oil Sales by Country (2021-2026) & (Tons) Table 129. Europe Pharmaceutical Grade CBD Oil Sales by Country (2027-2032) & (Tons) Table 130. Europe Pharmaceutical Grade CBD Oil Revenue by Country (2021-2026) & (US$ Million) Table 131. Europe Pharmaceutical Grade CBD Oil Revenue by Country (2027-2032) & (US$ Million) Table 132. Asia Pacific Pharmaceutical Grade CBD Oil Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Asia Pacific Pharmaceutical Grade CBD Oil Sales by Country (2021-2026) & (Tons) Table 134. Asia Pacific Pharmaceutical Grade CBD Oil Sales by Country (2027-2032) & (Tons) Table 135. Asia Pacific Pharmaceutical Grade CBD Oil Revenue by Country (2021-2026) & (US$ Million) Table 136. Asia Pacific Pharmaceutical Grade CBD Oil Revenue by Country (2027-2032) & (US$ Million) Table 137. South America Pharmaceutical Grade CBD Oil Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. South America Pharmaceutical Grade CBD Oil Sales by Country (2021-2026) & (Tons) Table 139. South America Pharmaceutical Grade CBD Oil Sales by Country (2027-2032) & (Tons) Table 140. South America Pharmaceutical Grade CBD Oil Revenue by Country (2021-2026) & (US$ Million) Table 141. South America Pharmaceutical Grade CBD Oil Revenue by Country (2027-2032) & (US$ Million) Table 142. Middle East and Africa Pharmaceutical Grade CBD Oil Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Middle East and Africa Pharmaceutical Grade CBD Oil Sales by Country (2021-2026) & (Tons) Table 144. Middle East and Africa Pharmaceutical Grade CBD Oil Sales by Country (2027-2032) & (Tons) Table 145. Middle East and Africa Pharmaceutical Grade CBD Oil Revenue by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa Pharmaceutical Grade CBD Oil Revenue by Country (2027-2032) & (US$ Million) Table 147. Global Pharmaceutical Grade CBD Oil Sales by Type (2021-2026) & (Tons) Table 148. Global Pharmaceutical Grade CBD Oil Sales by Type (2027-2032) & (Tons) Table 149. Global Pharmaceutical Grade CBD Oil Sales Market Share by Type (2021-2026) Table 150. Global Pharmaceutical Grade CBD Oil Sales Market Share by Type (2027-2032) Table 151. Global Pharmaceutical Grade CBD Oil Revenue by Type (2021-2026) & (US$ Million) Table 152. Global Pharmaceutical Grade CBD Oil Revenue by Type (2027-2032) & (US$ Million) Table 153. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Type (2021-2026) Table 154. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Type (2027-2032) Table 155. Global Pharmaceutical Grade CBD Oil Price by Type (2021-2026) & (US$/Kg) Table 156. Global Pharmaceutical Grade CBD Oil Price by Type (2027-2032) & (US$/Kg) Table 157. Global Pharmaceutical Grade CBD Oil Sales by Application (2021-2026) & (Tons) Table 158. Global Pharmaceutical Grade CBD Oil Sales by Application (2027-2032) & (Tons) Table 159. Global Pharmaceutical Grade CBD Oil Sales Market Share by Application (2021-2026) Table 160. Global Pharmaceutical Grade CBD Oil Sales Market Share by Application (2027-2032) Table 161. Global Pharmaceutical Grade CBD Oil Revenue by Application (2021-2026) & (US$ Million) Table 162. Global Pharmaceutical Grade CBD Oil Revenue by Application (2027-2032) & (US$ Million) Table 163. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Application (2021-2026) Table 164. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Application (2027-2032) Table 165. Global Pharmaceutical Grade CBD Oil Price by Application (2021-2026) & (US$/Kg) Table 166. Global Pharmaceutical Grade CBD Oil Price by Application (2027-2032) & (US$/Kg) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Pharmaceutical Grade CBD Oil Distributors List Table 170. Pharmaceutical Grade CBD Oil Customers List Table 171. Pharmaceutical Grade CBD Oil Industry Trends Table 172. Pharmaceutical Grade CBD Oil Industry Drivers Table 173. Pharmaceutical Grade CBD Oil Industry Restraints Table 174. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Pharmaceutical Grade CBD Oil Product Image Figure 5. Global Pharmaceutical Grade CBD Oil Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Pharmaceutical Grade CBD Oil Market Size (2021-2032) & (US$ Million) Figure 7. Global Pharmaceutical Grade CBD Oil Sales (2021-2032) & (Tons) Figure 8. Global Pharmaceutical Grade CBD Oil Average Price (US$/Kg) & (2021-2032) Figure 9. Full Spectrum CBD Oil Product Image Figure 10. Broad Spectrum CBD Oil Product Image Figure 11. Anxiety Product Image Figure 12. Diabetes Product Image Figure 13. Fibromyalgia Product Image Figure 14. Others Product Image Figure 15. Global Pharmaceutical Grade CBD Oil Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Pharmaceutical Grade CBD Oil, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Pharmaceutical Grade CBD Oil Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Pharmaceutical Grade CBD Oil Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Pharmaceutical Grade CBD Oil Sales by Region in 2025 Figure 21. Global Pharmaceutical Grade CBD Oil Revenue by Region in 2025 Figure 22. North America Pharmaceutical Grade CBD Oil Market Size by Country in 2025 Figure 23. North America Pharmaceutical Grade CBD Oil Sales Market Share by Country (2021-2032) Figure 24. North America Pharmaceutical Grade CBD Oil Revenue Market Share by Country (2021-2032) Figure 25. United States Pharmaceutical Grade CBD Oil Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Pharmaceutical Grade CBD Oil Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Pharmaceutical Grade CBD Oil Market Size by Country in 2025 Figure 28. Europe Pharmaceutical Grade CBD Oil Sales Market Share by Country (2021-2032) Figure 29. Europe Pharmaceutical Grade CBD Oil Revenue Market Share by Country (2021-2032) Figure 30. Germany Pharmaceutical Grade CBD Oil Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Pharmaceutical Grade CBD Oil Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Pharmaceutical Grade CBD Oil Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Pharmaceutical Grade CBD Oil Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Netherlands Pharmaceutical Grade CBD Oil Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Nordic Countries Pharmaceutical Grade CBD Oil Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Asia Pacific Pharmaceutical Grade CBD Oil Market Size by Country in 2025 Figure 37. Asia Pacific Pharmaceutical Grade CBD Oil Sales Market Share by Country (2021-2032) Figure 38. Asia Pacific Pharmaceutical Grade CBD Oil Revenue Market Share by Country (2021-2032) Figure 39. China Pharmaceutical Grade CBD Oil Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Japan Pharmaceutical Grade CBD Oil Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. South Korea Pharmaceutical Grade CBD Oil Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. India Pharmaceutical Grade CBD Oil Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Australia Pharmaceutical Grade CBD Oil Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. China Taiwan Pharmaceutical Grade CBD Oil Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Southeast Asia Pharmaceutical Grade CBD Oil Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Southeast Asia Pharmaceutical Grade CBD Oil Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South America Pharmaceutical Grade CBD Oil Market Size by Country in 2025 Figure 48. South America Pharmaceutical Grade CBD Oil Sales Market Share by Country (2021-2032) Figure 49. South America Pharmaceutical Grade CBD Oil Revenue Market Share by Country (2021-2032) Figure 50. Mexico Pharmaceutical Grade CBD Oil Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Brazil Pharmaceutical Grade CBD Oil Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Argentina Pharmaceutical Grade CBD Oil Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Middle East and Africa Pharmaceutical Grade CBD Oil Market Size by Country in 2025 Figure 54. Middle East and Africa Pharmaceutical Grade CBD Oil Sales Market Share by Country (2021-2032) Figure 55. Middle East and Africa Pharmaceutical Grade CBD Oil Revenue Market Share by Country (2021-2032) Figure 56. Turkey Pharmaceutical Grade CBD Oil Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Saudi Arabia Pharmaceutical Grade CBD Oil Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. UAE Pharmaceutical Grade CBD Oil Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Global Pharmaceutical Grade CBD Oil Sales Market Share by Type (2021-2032) Figure 60. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Type (2021-2032) Figure 61. Global Pharmaceutical Grade CBD Oil Price (US$/Kg) by Type (2021-2032) Figure 62. Global Pharmaceutical Grade CBD Oil Sales Market Share by Application (2021-2032) Figure 63. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Application (2021-2032) Figure 64. Global Pharmaceutical Grade CBD Oil Price (US$/Kg) by Application (2021-2032) Figure 65. Pharmaceutical Grade CBD Oil Value Chain Figure 66. Pharmaceutical Grade CBD Oil Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Pharmaceutical Grade CBD Oil Industry Opportunities and Challenges

Scope & coverage.

Types
  • Full Spectrum CBD Oil
  • Broad Spectrum CBD Oil
Applications
  • Anxiety
  • Diabetes
  • Fibromyalgia
  • Others
Companies covered
  • Absolute Terps
  • Aphria
  • Cannavest
  • Canopy Growth Corporation
  • CBD American Shaman
  • Charlotte's Web
  • Emblem Cannabis Oils
  • ENDOCA
  • Folium Biosciences
  • GL Brands, Inc.
  • Green Road
  • HempLife Today
  • K.I.N.D. Concentrates
  • Kazmira
  • Medical Marijuana, Inc.
  • NuLeaf Naturals
  • PHARM-CBD, LLC
  • The Lab
  • Whistler

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Pharmaceutical Grade CBD Oil Market Size (2021-2032)
  4. 2.2.2 Global Pharmaceutical Grade CBD Oil Sales (2021-2032)
  5. 2.2.3 Global Pharmaceutical Grade CBD Oil Market Average Price (2021-2032)
  6. 2.3 Pharmaceutical Grade CBD Oil by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Full Spectrum CBD Oil
  9. 2.3.3 Broad Spectrum CBD Oil
  10. 2.4 Pharmaceutical Grade CBD Oil by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Anxiety
  13. 2.4.3 Diabetes
  14. 2.4.4 Fibromyalgia
  15. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Pharmaceutical Grade CBD Oil Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Pharmaceutical Grade CBD Oil Sales (Tons) of Manufacturers (2021-2026)
  3. 3.3 Global Pharmaceutical Grade CBD Oil Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Pharmaceutical Grade CBD Oil Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Pharmaceutical Grade CBD Oil Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Pharmaceutical Grade CBD Oil, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Pharmaceutical Grade CBD Oil, Product Type & Application
  8. 3.8 Global Manufacturers of Pharmaceutical Grade CBD Oil, Established Date
  9. 3.9 Global Pharmaceutical Grade CBD Oil Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Absolute Terps
  2. 4.1.1 Absolute Terps Company Information
  3. 4.1.2 Absolute Terps Business Overview
  4. 4.1.3 Absolute Terps Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Absolute Terps Pharmaceutical Grade CBD Oil Product Portfolio
  6. 4.1.5 Absolute Terps Recent Developments
  7. 4.2 Aphria
  8. 4.2.1 Aphria Company Information
  9. 4.2.2 Aphria Business Overview
  10. 4.2.3 Aphria Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Aphria Pharmaceutical Grade CBD Oil Product Portfolio
  12. 4.2.5 Aphria Recent Developments
  13. 4.3 Cannavest
  14. 4.3.1 Cannavest Company Information
  15. 4.3.2 Cannavest Business Overview
  16. 4.3.3 Cannavest Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Cannavest Pharmaceutical Grade CBD Oil Product Portfolio
  18. 4.3.5 Cannavest Recent Developments
  19. 4.4 Canopy Growth Corporation
  20. 4.4.1 Canopy Growth Corporation Company Information
  21. 4.4.2 Canopy Growth Corporation Business Overview
  22. 4.4.3 Canopy Growth Corporation Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Canopy Growth Corporation Pharmaceutical Grade CBD Oil Product Portfolio
  24. 4.4.5 Canopy Growth Corporation Recent Developments
  25. 4.5 CBD American Shaman
  26. 4.5.1 CBD American Shaman Company Information
  27. 4.5.2 CBD American Shaman Business Overview
  28. 4.5.3 CBD American Shaman Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 CBD American Shaman Pharmaceutical Grade CBD Oil Product Portfolio
  30. 4.5.5 CBD American Shaman Recent Developments
  31. 4.6 Charlotte's Web
  32. 4.6.1 Charlotte's Web Company Information
  33. 4.6.2 Charlotte's Web Business Overview
  34. 4.6.3 Charlotte's Web Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Charlotte's Web Pharmaceutical Grade CBD Oil Product Portfolio
  36. 4.6.5 Charlotte's Web Recent Developments
  37. 4.7 Emblem Cannabis Oils
  38. 4.7.1 Emblem Cannabis Oils Company Information
  39. 4.7.2 Emblem Cannabis Oils Business Overview
  40. 4.7.3 Emblem Cannabis Oils Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Emblem Cannabis Oils Pharmaceutical Grade CBD Oil Product Portfolio
  42. 4.7.5 Emblem Cannabis Oils Recent Developments
  43. 4.8 ENDOCA
  44. 4.8.1 ENDOCA Company Information
  45. 4.8.2 ENDOCA Business Overview
  46. 4.8.3 ENDOCA Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 ENDOCA Pharmaceutical Grade CBD Oil Product Portfolio
  48. 4.8.5 ENDOCA Recent Developments
  49. 4.9 Folium Biosciences
  50. 4.9.1 Folium Biosciences Company Information
  51. 4.9.2 Folium Biosciences Business Overview
  52. 4.9.3 Folium Biosciences Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Folium Biosciences Pharmaceutical Grade CBD Oil Product Portfolio
  54. 4.9.5 Folium Biosciences Recent Developments
  55. 4.10 GL Brands, Inc.
  56. 4.10.1 GL Brands, Inc. Company Information
  57. 4.10.2 GL Brands, Inc. Business Overview
  58. 4.10.3 GL Brands, Inc. Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 GL Brands, Inc. Pharmaceutical Grade CBD Oil Product Portfolio
  60. 4.10.5 GL Brands, Inc. Recent Developments
  61. 4.11 Green Road
  62. 4.11.1 Green Road Company Information
  63. 4.11.2 Green Road Business Overview
  64. 4.11.3 Green Road Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Green Road Pharmaceutical Grade CBD Oil Product Portfolio
  66. 4.11.5 Green Road Recent Developments
  67. 4.12 HempLife Today
  68. 4.12.1 HempLife Today Company Information
  69. 4.12.2 HempLife Today Business Overview
  70. 4.12.3 HempLife Today Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 HempLife Today Pharmaceutical Grade CBD Oil Product Portfolio
  72. 4.12.5 HempLife Today Recent Developments
  73. 4.13 K.I.N.D. Concentrates
  74. 4.13.1 K.I.N.D. Concentrates Company Information
  75. 4.13.2 K.I.N.D. Concentrates Business Overview
  76. 4.13.3 K.I.N.D. Concentrates Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 K.I.N.D. Concentrates Pharmaceutical Grade CBD Oil Product Portfolio
  78. 4.13.5 K.I.N.D. Concentrates Recent Developments
  79. 4.14 Kazmira
  80. 4.14.1 Kazmira Company Information
  81. 4.14.2 Kazmira Business Overview
  82. 4.14.3 Kazmira Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Kazmira Pharmaceutical Grade CBD Oil Product Portfolio
  84. 4.14.5 Kazmira Recent Developments
  85. 4.15 Medical Marijuana, Inc.
  86. 4.15.1 Medical Marijuana, Inc. Company Information
  87. 4.15.2 Medical Marijuana, Inc. Business Overview
  88. 4.15.3 Medical Marijuana, Inc. Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Medical Marijuana, Inc. Pharmaceutical Grade CBD Oil Product Portfolio
  90. 4.15.5 Medical Marijuana, Inc. Recent Developments
  91. 4.16 NuLeaf Naturals
  92. 4.16.1 NuLeaf Naturals Company Information
  93. 4.16.2 NuLeaf Naturals Business Overview
  94. 4.16.3 NuLeaf Naturals Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 NuLeaf Naturals Pharmaceutical Grade CBD Oil Product Portfolio
  96. 4.16.5 NuLeaf Naturals Recent Developments
  97. 4.17 PHARM-CBD, LLC
  98. 4.17.1 PHARM-CBD, LLC Company Information
  99. 4.17.2 PHARM-CBD, LLC Business Overview
  100. 4.17.3 PHARM-CBD, LLC Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 PHARM-CBD, LLC Pharmaceutical Grade CBD Oil Product Portfolio
  102. 4.17.5 PHARM-CBD, LLC Recent Developments
  103. 4.18 The Lab
  104. 4.18.1 The Lab Company Information
  105. 4.18.2 The Lab Business Overview
  106. 4.18.3 The Lab Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 The Lab Pharmaceutical Grade CBD Oil Product Portfolio
  108. 4.18.5 The Lab Recent Developments
  109. 4.19 Whistler
  110. 4.19.1 Whistler Company Information
  111. 4.19.2 Whistler Business Overview
  112. 4.19.3 Whistler Pharmaceutical Grade CBD Oil Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Whistler Pharmaceutical Grade CBD Oil Product Portfolio
  114. 4.19.5 Whistler Recent Developments
5 Global Pharmaceutical Grade CBD Oil Market Scenario by Region
  1. 5.1 Global Pharmaceutical Grade CBD Oil Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Pharmaceutical Grade CBD Oil Sales by Region: 2021-2032
  3. 5.2.1 Global Pharmaceutical Grade CBD Oil Sales by Region: 2021-2026
  4. 5.2.2 Global Pharmaceutical Grade CBD Oil Sales by Region: 2027-2032
  5. 5.3 Global Pharmaceutical Grade CBD Oil Revenue by Region: 2021-2032
  6. 5.3.1 Global Pharmaceutical Grade CBD Oil Revenue by Region: 2021-2026
  7. 5.3.2 Global Pharmaceutical Grade CBD Oil Revenue by Region: 2027-2032
  8. 5.4 North America Pharmaceutical Grade CBD Oil Market Facts & Figures by Country
  9. 5.4.1 North America Pharmaceutical Grade CBD Oil Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Pharmaceutical Grade CBD Oil Sales by Country (2021-2032)
  11. 5.4.3 North America Pharmaceutical Grade CBD Oil Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Pharmaceutical Grade CBD Oil Market Facts & Figures by Country
  15. 5.5.1 Europe Pharmaceutical Grade CBD Oil Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Pharmaceutical Grade CBD Oil Sales by Country (2021-2032)
  17. 5.5.3 Europe Pharmaceutical Grade CBD Oil Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.5.9 Nordic Countries
  24. 5.6 Asia Pacific Pharmaceutical Grade CBD Oil Market Facts & Figures by Country
  25. 5.6.1 Asia Pacific Pharmaceutical Grade CBD Oil Market Size by Country: 2021 VS 2025 VS 2032
  26. 5.6.2 Asia Pacific Pharmaceutical Grade CBD Oil Sales by Country (2021-2032)
  27. 5.6.3 Asia Pacific Pharmaceutical Grade CBD Oil Revenue by Country (2021-2032)
  28. 5.6.4 China
  29. 5.6.5 Japan
  30. 5.6.6 South Korea
  31. 5.6.7 India
  32. 5.6.8 Australia
  33. 5.6.9 China Taiwan
  34. 5.6.10 Southeast Asia
  35. 5.7 South America Pharmaceutical Grade CBD Oil Market Facts & Figures by Country
  36. 5.7.1 South America Pharmaceutical Grade CBD Oil Market Size by Country: 2021 VS 2025 VS 2032
  37. 5.7.2 South America Pharmaceutical Grade CBD Oil Sales by Country (2021-2032)
  38. 5.7.3 South America Pharmaceutical Grade CBD Oil Revenue by Country (2021-2032)
  39. 5.7.4 Mexico
  40. 5.7.5 Brazil
  41. 5.7.6 Argentina
  42. 5.8 Middle East and Africa Pharmaceutical Grade CBD Oil Market Facts & Figures by Country
  43. 5.8.1 Middle East and Africa Pharmaceutical Grade CBD Oil Market Size by Country: 2021 VS 2025 VS 2032
  44. 5.8.2 Middle East and Africa Pharmaceutical Grade CBD Oil Sales by Country (2021-2032)
  45. 5.8.3 Middle East and Africa Pharmaceutical Grade CBD Oil Revenue by Country (2021-2032)
  46. 5.8.4 Turkey
  47. 5.8.5 Saudi Arabia
  48. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Pharmaceutical Grade CBD Oil Sales by Type (2021-2032)
  2. 6.1.1 Global Pharmaceutical Grade CBD Oil Sales by Type (2021-2032) & (Tons)
  3. 6.1.2 Global Pharmaceutical Grade CBD Oil Sales Market Share by Type (2021-2032)
  4. 6.2 Global Pharmaceutical Grade CBD Oil Revenue by Type (2021-2032)
  5. 6.2.1 Global Pharmaceutical Grade CBD Oil Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Pharmaceutical Grade CBD Oil Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Pharmaceutical Grade CBD Oil Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Pharmaceutical Grade CBD Oil Sales by Application (2021-2032)
  2. 7.1.1 Global Pharmaceutical Grade CBD Oil Sales by Application (2021-2032) & (Tons)
  3. 7.1.2 Global Pharmaceutical Grade CBD Oil Sales Market Share by Application (2021-2032)
  4. 7.2 Global Pharmaceutical Grade CBD Oil Revenue by Application (2021-2032)
  5. 7.2.1 Global Pharmaceutical Grade CBD Oil Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Pharmaceutical Grade CBD Oil Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Pharmaceutical Grade CBD Oil Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Pharmaceutical Grade CBD Oil Value Chain Analysis
  2. 8.1.1 Pharmaceutical Grade CBD Oil Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Pharmaceutical Grade CBD Oil Production Mode & Process
  5. 8.2 Pharmaceutical Grade CBD Oil Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Pharmaceutical Grade CBD Oil Distributors
  8. 8.2.3 Pharmaceutical Grade CBD Oil Customers
9 Global Pharmaceutical Grade CBD Oil Analyzing Market Dynamics
  1. 9.1 Pharmaceutical Grade CBD Oil Industry Trends
  2. 9.2 Pharmaceutical Grade CBD Oil Industry Drivers
  3. 9.3 Pharmaceutical Grade CBD Oil Industry Opportunities and Challenges
  4. 9.4 Pharmaceutical Grade CBD Oil Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst